Filing Details

Accession Number:
0000904454-20-000590
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-20 18:22:37
Reporting Period:
2020-08-18
Accepted Time:
2020-08-20 18:22:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1000694 Novavax Inc NVAX Biological Products, (No Disgnostic Substances) (2836) 222816046
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1051997 Jr A Michael Mcmanus C/O Novavax, Inc.
21 Firstfield Road
Gaithersburg MD 20878
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-08-18 4,000 $27.60 13,951 No 4 M Direct
Common Stock Acquisiton 2020-08-18 4,000 $27.60 17,951 No 4 M Direct
Common Stock Disposition 2020-08-18 8,000 $146.00 9,951 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2020-08-18 4,000 $0.00 4,000 $27.60
Common Stock Stock Option (Right to Buy) Disposition 2020-08-18 4,000 $0.00 4,000 $27.60
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2018-03-16 2027-03-16 No 4 M Direct
0 2018-12-15 2027-12-15 No 4 M Direct